Enterococci were frequently considered to be commensal organism and were ignored when isolated in clinical laboratory. But recently due to its capability of causing variety of infections, especially in hospitalized patients and difference in antimicrobial sensitivity of each species to varying antibiotics the present study was undertaken with a view at characterizing the clinical isolates of enterococcus, recovered from the cases of urinary tract infections (UTI). A total of 59 Enterococci were isolated from UTI patient for a period of 1 year. In the present study it was the 3rd leading organism causing UTI. They were speciated by an identification system based on the phenotypic characteristics of enterococcus species and their antimicrobial sensitivity pattern was determined. Most of the isolates were E.faecalis 42(71.18%) followed by E.faecium accounted for 10(16.94%), E.avium 1(2.43%), E.raff 1(2.43%) and 5(8.47%) remained unidentified. E.faecium showed increased resistance to amoxicillin (90%), co-trimoxazole (80%), ciprofloxacin (70%), gentamycin (80%), ceftriaxone (90%), and cefuroxime (80%). Most of the E.faecalis was resistant to amoxicillin (66.66%), cotrimoxazole (71.42%), ciprofloxacin (76.19%), gentamycin (71.42%), ceftriaxone (64.28%) and cefuroxime (80.95%). Multidrug-resistant enterococci are emerging as a leading nosocomial uropathogen. Identification of species along with knowledge of the antimicrobial resistance profile may ultimately contribute to development of strategies for prevention and to formulate treatment guidelines for infections caused by enterococci.
Introduction:
Enterococci, an indigenous flora of the intestinal tract, oral cavity and the genitourinary tract of the humans and animals, are known to be relatively a virulent in healthy individuals, but have become important opportunistic pathogens, especially in hospitalized patients 1 .Recent years have witnessed increased interest in enterococci not only because of their ability to cause serious infections like urinary tract infection (UTI), endocarditis, bacteremia, intra-abdominal infections but also because of their increasing resistance to many antimicrobial agents 2 . Among the 28 or more species identified Enterococcus faecalis causes 80-90 percent of human enterococcal infections while E. faecium accounts for majority of the remainder.
Although enterococci were not previously thought of as nosocomially spread pathogens, recent studies have confirmed this route of transmission 1 accounting for approximately 10% of hospital acquired infections 3 , 10-20% hospital acquired urinary tract infections. A center for disease control (CDC) 4 survey of nosocomial infection, enterococci ranked third most common cause of hospital-acquired infections (HAI) after Escherichia coli, S.aureus and Pseudomonas aeruginosa and accounted for 13.9% of urinary tract infection 5 . The increasing resistance to antibacterial agent such as penicillin, aminoglycoside, trimethoprim and also to glycopeptide such as vancomycin and teicoplanin created an increasingly worrisome problem in clinical practice. This emphasizes the need for their identification from the clinical specimens and also differentiates them from other group D streptococci which are generally more sensitive Bangladesh J Med Microbiol Volume 8: Number 1 January, 2014
to the antimicrobial agents. The study was designed to determine the frequency of isolation of different species of enterococci causing UTI and the antimicrobial resistance pattern of the isolated species,
Materials & Methods
In this study a total 1203 urine samples were tested for the isolation of Enterococci from urine of suspected urinary tract infection patients of outpatient and inpatient department of BSMMU, Dhaka from January 2010 to December 2010. The urine specimens having pus cells (more than 5 cells per high power field from un-centrifuged urine) on microscopy were included. All samples were initially cultured on chromogenic agar media (Difco laboratories, Detroit, USA). They were sub cultured on blood agar plates at 37 o c for 24 hrs. All suspected colonies were identified by standered microbiological methods including gram staining, catalase test and esculin hydrolysis test, growth in 6.5% NaCI and at pH 9.6 6 .
Identification of species
Enterococcal strains were identified to the species level by using conventional physiological tests devised by Facklam and Collins 7 which are based on carbohydrate fermentation using 1% solution of following sugars: mannitol, sorbitol, arabinose raffinose, sorbose, lactose, and; by pyruvate utilization in 1% pyruvate broth; arginine decarboxylation in Moellers decarboxylase broth; motility was determined in modified Difco motility medium, and pigmentation was observed after overnight growth on tryptic soy agar. If the culture produced pigment, yellow was observed on a cotton swab that was used to pick up growth from the tryptic soy agar plate. All of the medium formulations and interpretations of tests used are described in the Manual of Clinical Microbiology, 4th ed 6 .
Antibiotic sensitivity testing:
Antibacterial resistance pattern of 9 antimicrobial agents were performed with Amoxicillin, Cotrimoxazole, Ciprofloxacin, Nitrofurantoin, Ceftriaxone, Gentamycin, Cefuroxime, Imipenem, Vancomycin using standard disk diffution method (Kirby-Bauer sensitivity test) 8 susceptibility test. All test were performed on Muller Hinton agar (Oxoid Co, Hampshire, UK ), and results read after 24 hrs of incubation at 37 o c.
Results
A total of 59 enterococci were isolated from urine specimens (N=1,203) during the study period corresponding to 8.44% of all positive urine cultures. In this study significant growth of different organism occurred in 55.36% of cases. Based on the biochemical reactions, only 55 enterococci could be speciated. E. faecalis (71.18%) was the most common species isolated followed by E.faecium accounted for 10(16.94%), E.avium 1(2.43%), E.raff 1(2.43%) and 5(8.47%) remained unidentified.
On the basis of the results of four physiologic tests (acidification of mannitol, sorbitol, and sorbose broths, as well as failure to deaminate arginine), Enterococci were placed in three groups identified as I, II, and III (Table I) . Twelve species and 1 variant species of Enterococci were placed in three groups. Table II showed one E.avium and one E.raff from group I are speciated by using acidification of arabinose and raffinose broths. Fifty two enterococci from group II are speciated using acidification of pyruvate and arabinose broth. Fourty two E. faecalis utilized pyruvate but did't produce acid from arabinose and 10 E.faecium produced acid from arabinose but did'nt utilized pyruvate (Table III) 12 . They cultured all urine samples irrespective of pus cell which may be the reason for lower percentage of growth than that of the present study.
In the present study, regarding incidence of various species of Enterococci found almost similar to other studies, E.faecalis (71.18%) was the most commonly identified species isolated from urine specimens followed by E.faecium (16.94% 8 (80) 8 (80) 2 (20) 9 (90) 8 (80) 8 (80) 1 (10) 1 (10) 28 ( Resistance to several antimicrobial agents was prevalent among the Enterococci isolates recovered in the hospital. Knowledge of the antimicrobial resistance profile is essential to formulate treatment guidelines for infections caused by Enterococci.
Isolates of E. faecium were found in our study to be more multi-resistant than E. faecalis. E. faecium isolates were significantly more resistant to amoxicillin, cotrimoxazole, ciprofloxacin, ceftriaxone. Almeida and colleagues reported a higher percentage of resistance in E. faecalis to ampicillin, penicillin, aminoglycosides, chloramphenicol, ciprofloxacin, rifampicin, and erythromycin while E. faecium isolates exhibited more resistance to tetracyclines 16 . Regarding the unusual species of Enterococcus, the susceptibility patterns did not show any major differences.
Amoxicillin resistance in E. faecium was significantly higher and this finding is similar to the report of Jureen et al(2003) 18 . According to their study this kind of resistance in Enterococci may be due to the production of low-affinity penicillin-binding protein. Cotrimoxazole resistant Enterococci have been isolated worldwide 19 . In the present study, 70-80% of the Enterococci are gentamycin resistant. Gentamicin is one of the most commonly used aminoglycosides against enterococci. High level aminoglycoside resistance is a real problem. This resistance overcomes the synergy of killing combination therapy. Ampicilin and vancomycin are not bactericidal unless combined with an aminoglycoside. High level gentamycin resistance is most often associated with high-level resistance to all alternative aminoglysides.
The high resistance to ciprofloxacin seen in the present study may be due to the widespread usage of these antibiotics for UTI as a first-line treatment in our country. There are also reports of increasing resistance of Enterococci to ciprofloxacin 20 Resistance of Enterococci to glycopeptides poses an increasing problem in clinical practice in many countries around the world21. The prevalence of vancomycin resistant E. faecium in health care institutions across United States is reported to be 15% 4 . In our isolates we did not found any vancomycin resistant Enterococci.
The susceptibility pattern of enterococci against nitrofurantoin is very promising 22 . In our study, enterococci not only showed significantly very high susceptibility against nitrofurantoin (86.44%) but most of the isolates, which were found resistant to other available antibiotics, were found susceptible to nitrofurantoin.
Conclusion
For long time, enterococci were considered to be commensal organism and were ignored when isolated in clinical laboratory. But recently due to its capability of causing variety of infections, especially in hospitalized patients and difference in antimicrobial sensitivity of each species to varying antibiotics has led to understanding the importance of identification of Enterococcus to species level. The increased resistance to major antibiotic classes emphasizes, once more, not only on the necessity for more discriminate use of new drugs but also for continuous efforts to find or design antimicrobial agents. Thus, we suggest intensified actions to promote more the rational use of antibiotics in health care settings, more surveillance studies in order to monitor changes in enterococcal resistance patterns and the adoption of measures to prevent the spreading of resistance isolates.
